Wouter B. Nagengast

5.4k total citations · 2 hit papers
91 papers, 3.4k citations indexed

About

Wouter B. Nagengast is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, Wouter B. Nagengast has authored 91 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Pulmonary and Respiratory Medicine, 39 papers in Surgery and 32 papers in Oncology. Recurrent topics in Wouter B. Nagengast's work include Esophageal Cancer Research and Treatment (31 papers), Gastric Cancer Management and Outcomes (24 papers) and Nanoplatforms for cancer theranostics (13 papers). Wouter B. Nagengast is often cited by papers focused on Esophageal Cancer Research and Treatment (31 papers), Gastric Cancer Management and Outcomes (24 papers) and Nanoplatforms for cancer theranostics (13 papers). Wouter B. Nagengast collaborates with scholars based in Netherlands, Germany and United States. Wouter B. Nagengast's co-authors include Elisabeth G.E. de Vries, Hetty Timmer‐Bosscha, Gooitzen M. van Dam, Urszula Domańska, Roeliene C. Kruizinga, Annemiek Walenkamp, Gerwin Huls, Marjolijn N. Lub–de Hooge, Vasilis Ntziachristos and Harry Hollema and has published in prestigious journals such as Circulation, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Wouter B. Nagengast

87 papers receiving 3.3k citations

Hit Papers

A review on CXCR4/CXCL12 axis in oncology: No place to hide 2012 2026 2016 2021 2012 2018 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. A review on CXCR4/CXCL12 axis in oncology: No place to hide
    2012 510 citations Wouter B. Nagengast, Elisabeth G.E. de Vries et al. profile →
  2. Heart Failure Stimulates Tumor Growth by Circulating Factors
    2018 241 citations Wouter B. Nagengast et al. profile →

Peers

Wouter B. Nagengast
Rutger‐Jan Swijnenburg Netherlands
Hui Zhu China
John Gutheil United States
Marjolijn N. Lub–de Hooge Netherlands
Jeffrey Y.C. Wong United States
J. Sven D. Mieog Netherlands
Marianne Nordsmark Denmark
Frank Saran United Kingdom
Holly E. Barker United Kingdom
Peter Bronsert Germany
Rutger‐Jan Swijnenburg Netherlands
Wouter B. Nagengast
Citations per year, relative to Wouter B. Nagengast Wouter B. Nagengast (= 1×) peers Rutger‐Jan Swijnenburg

Countries citing papers authored by Wouter B. Nagengast

Since Specialization
Citations

This map shows the geographic impact of Wouter B. Nagengast's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wouter B. Nagengast with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wouter B. Nagengast more than expected).

Fields of papers citing papers by Wouter B. Nagengast

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wouter B. Nagengast. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wouter B. Nagengast. The network helps show where Wouter B. Nagengast may publish in the future.

Co-authorship network of co-authors of Wouter B. Nagengast

This figure shows the co-authorship network connecting the top 25 collaborators of Wouter B. Nagengast. A scholar is included among the top collaborators of Wouter B. Nagengast based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wouter B. Nagengast. Wouter B. Nagengast is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Gorpas, Dimitris, et al.. (2025). P0944 Fluorescently labelled adalimumab to visualise drug targeting in Inflammatory Bowel Disease: a safety, feasibility and dose-finding study. Journal of Crohn s and Colitis. 19(Supplement_1). i1765–i1766. 1 indexed citations
3.
Ven, Steffi E. M. van de, Bas L. Weusten, Lorenza Alvarez Herrero, et al.. (2024). Vertical tumor-positive resection margins and the risk of residual neoplasia after endoscopic resection of Barrett’s neoplasia: a nationwide cohort with pathology reassessment. Endoscopy. 56(8). 559–568. 3 indexed citations
4.
Linssen, Matthijs D., Michael Dobosz, Dominic J. Robinson, et al.. (2024). Fluorescently labelled vedolizumab to visualise drug distribution and mucosal target cells in inflammatory bowel disease. Gut. 73(9). 1454–1463. 7 indexed citations
5.
Schmidt, Iris, Gert Jan Meersma, Jan Willem Haveman, et al.. (2024). Ultrasound-Guided Quantitative Fluorescence Molecular Endoscopy for Monitoring Response in Patients with Esophageal Cancer Following Neoadjuvant Chemoradiotherapy. Clinical Cancer Research. 30(15). 3211–3219. 2 indexed citations
6.
Schmidt, Iris, Gerrit van den Berg, Astrid G. W. Korsten‐Meijer, et al.. (2024). Fluorescence detection of pituitary neuroendocrine tumour during endoscopic transsphenoidal surgery using bevacizumab-800CW: a non-randomised, non-blinded, single centre feasibility and dose finding trial [DEPARTURE trial]. European Journal of Nuclear Medicine and Molecular Imaging. 52(2). 660–668. 2 indexed citations
7.
Schmidt, Iris, et al.. (2023). Detection of Tumour-Targeted IRDye800CW Tracer with Commercially Available Laparoscopic Surgical Systems. Diagnostics. 13(9). 1591–1591. 5 indexed citations
8.
Burghgraef, Thijs A., Halil Akol, Matthijs P. Schwartz, et al.. (2023). Robot-assisted fluorescent sentinel lymph node identification in early-stage colon cancer. Surgical Endoscopy. 37(11). 8394–8403. 6 indexed citations
9.
Putten, Joost van der, Xiaojuan Zhao, Arend Karrenbeld, et al.. (2023). Optical Biopsy of Dysplasia in Barrett’s Oesophagus Assisted by Artificial Intelligence. Cancers. 15(7). 1950–1950. 3 indexed citations
10.
Burghgraef, Thijs A., A. Vos, David W. da Costa, et al.. (2023). Nationwide practice in CT-based preoperative staging of colon cancer and concordance with definitive pathology. European Journal of Surgical Oncology. 49(10). 106941–106941. 10 indexed citations
11.
Zhao, Xiaojuan, Marjory Koller, Gert Jan Meersma, et al.. (2022). Validation of Novel Molecular Imaging Targets Identified by Functional Genomic mRNA Profiling to Detect Dysplasia in Barrett’s Esophagus. Cancers. 14(10). 2462–2462. 4 indexed citations
12.
Steinkamp, Pieter J., Jasper Vonk, Gilles F.H. Diercks, et al.. (2021). VEGF-Targeted Multispectral Optoacoustic Tomography and Fluorescence Molecular Imaging in Human Carotid Atherosclerotic Plaques. Diagnostics. 11(7). 1227–1227. 8 indexed citations
13.
Zhao, Xiaojuan, Qingfeng Huang, Marjory Koller, et al.. (2021). Identification and Validation of Esophageal Squamous Cell Carcinoma Targets for Fluorescence Molecular Endoscopy. International Journal of Molecular Sciences. 22(17). 9270–9270. 5 indexed citations
14.
Nieuwenhuis, Esther, Sybren L. Meijer, Lodewijk A.A. Brosens, et al.. (2021). Extending treatment criteria for Barrett’s neoplasia: results of a nationwide cohort of 138 endoscopic submucosal dissection procedures. Endoscopy. 54(6). 531–541. 15 indexed citations
15.
16.
Festen, Eleonora A., et al.. (2020). Endoscopic imaging in inflammatory bowel disease: current developments and emerging strategies. Expert Review of Gastroenterology & Hepatology. 15(2). 115–126. 11 indexed citations
17.
Tjalma, Jolien J., Marjory Koller, Matthijs D. Linssen, et al.. (2019). Quantitative fluorescence endoscopy: an innovative endoscopy approach to evaluate neoadjuvant treatment response in locally advanced rectal cancer. Gut. 69(3). 406–410. 45 indexed citations
18.
Vries, Elisabeth G.E. de, Thijs H. Oude Munnink, Marcel A.T.M. van Vugt, & Wouter B. Nagengast. (2011). Toward Molecular Imaging–Driven Drug Development in Oncology. Cancer Discovery. 1(1). 25–28. 20 indexed citations
19.
Nagengast, Wouter B., Marjolijn N. Lub–de Hooge, Sjoukje F. Oosting, et al.. (2010). VEGF-PET Imaging Is a Noninvasive Biomarker Showing Differential Changes in the Tumor during Sunitinib Treatment. Cancer Research. 71(1). 143–153. 83 indexed citations
20.
Wipke, Brian T., Zheng Wang, Wouter B. Nagengast, David E. Reichert, & Paul M. Allen. (2004). Staging the Initiation of Autoantibody-Induced Arthritis: A Critical Role for Immune Complexes. The Journal of Immunology. 172(12). 7694–7702. 112 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rutger‐Jan Swijnenburg Breakdown of academic impact, for papers by Hui Zhu Breakdown of academic impact, for papers by John Gutheil Breakdown of academic impact, for papers by Marjolijn N. Lub–de Hooge Breakdown of academic impact, for papers by Jeffrey Y.C. Wong Breakdown of academic impact, for papers by J. Sven D. Mieog Breakdown of academic impact, for papers by Marianne Nordsmark Breakdown of academic impact, for papers by Frank Saran Breakdown of academic impact, for papers by Holly E. Barker Breakdown of academic impact, for papers by Peter Bronsert
Rankless by CCL
2026